Comparing two laser eye treatments for glaucoma pressure control

This trial is testing whether a newer laser technique called Direct Selective Laser Trabeculoplasty (DSLT) works as well as the standard Selective Laser Trabeculoplasty (SLT) for lowering eye pressure in people with open-angle glaucoma. Both treatments are already FDA-approved and used in regular care. Researchers want to see if the newer method is easier and more comfortable for patients while being just as effective at preventing vision loss.

Open-angle glaucoma damages vision by increasing pressure inside the eye, and laser treatment is an important option when eye drops alone aren't enough. This study exists to see whether the newer, non-contact version of this treatment works as well or better than the traditional approach, which could make the procedure more comfortable and efficient for patients.